Trials / Completed
CompletedNCT01381302
Trodat 1 SPECT and Dopamine Polymorphism
Association of Polymorphism in Genes Associated With Control of Dopamine Levels in Parkinson's Disease and Tc-99m-Trodat-1 SPECT Imaging.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (actual)
- Sponsor
- Wolfson Medical Center · Other Government
- Sex
- All
- Age
- 35 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The study population will include 100 parkinsonian patients in early stage of disease, with total duration not exeeding 5 years. The patients will undergo neurologic examination and evaluation of disease severity using the unified PD rating scale. Subsequently a brain SPECT will be performed using Tc-99m-Trodat1.
Detailed description
The study sample will include 100 Israeli Jewish patients with early idiopathic PD who were not treated with anti-parkinson drugs. The clinical diagnosis will be based on the criteria of the United Kingdom Parkinson Disease Society Brain Bank.5 All patients will undergo Tc-99m-Trodat1 SPECT. The severity of the motor symptoms will be assessed with the Unified PD Rating Scale (UPDRS). Genomic DNA is extracted from peripheral blood leukocytes for genetic analysis.
Conditions
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2011-06-27
- Last updated
- 2016-02-09
Locations
2 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT01381302. Inclusion in this directory is not an endorsement.